2024 Biopharma Investment Outlook with Chris Dokomajilar

Chris Dokomajilar from DealForma joins this podcast by RX for Biotech to explore the investment trends in advanced therapies and AI within biopharma, using insights from DealForma’s detailed life science database.

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures